BACKGROUND:Iron status degrades in female soldiers during military training. Inflammation-mediated up-regulation of hepcidin, a key mediator of iron homeostasis, may be a contributing factor. OBJECTIVE: We measured the efficacy of an iron-fortified food product for maintaining iron status in female soldiers during basic combat training (BCT) and examined relations between iron status, serum hepcidin concentrations, and inflammation. DESIGN: A randomized, double-blind, placebo-controlled trial was conducted. Volunteers received an iron-fortified food product (total dose = 56 mg Fe/d) or a placebo twice daily during the 9-wk BCT course. Iron-status indicators, serum hepcidin concentrations, and markers of inflammation were measured pre- and post-BCT. RESULTS:BCT affected iron status; serum ferritin concentrations decreased (P < or = 0.05), and concentrations of soluble transferrin receptor (sTfR) and hemoglobin and the red cell distribution width increased (P < or = 0.05). Consumption of the iron-fortified food product attenuated declines in iron status in iron-deficient anemic soldiers; a group-by-time interaction was observed for hemoglobin and sTfR concentrations (P < or = 0.05). Serum hepcidin concentrations were not affected by BCT; however, hepcidin concentrations were lower in iron-deficient anemic soldiers than in those with normal iron status (P < or = 0.05) and were positively associated with serum ferritin (P < or = 0.05) and C-reactive protein (P < or = 0.05) concentrations pre- and post-BCT. CONCLUSIONS: Twice-daily consumption of an iron-fortified food product improved iron status in iron-deficient anemic soldiers but not in iron-normal or iron-deficient nonanemic soldiers. Serum hepcidin concentrations were not affected by training but were associated with iron status and inflammation pre- and post-BCT. This trial was registered at clinicaltrials.gov as NCT01100905.
RCT Entities:
BACKGROUND:Iron status degrades in female soldiers during military training. Inflammation-mediated up-regulation of hepcidin, a key mediator of iron homeostasis, may be a contributing factor. OBJECTIVE: We measured the efficacy of an iron-fortified food product for maintaining iron status in female soldiers during basic combat training (BCT) and examined relations between iron status, serum hepcidin concentrations, and inflammation. DESIGN: A randomized, double-blind, placebo-controlled trial was conducted. Volunteers received an iron-fortified food product (total dose = 56 mg Fe/d) or a placebo twice daily during the 9-wk BCT course. Iron-status indicators, serum hepcidin concentrations, and markers of inflammation were measured pre- and post-BCT. RESULTS:BCT affected iron status; serum ferritin concentrations decreased (P < or = 0.05), and concentrations of soluble transferrin receptor (sTfR) and hemoglobin and the red cell distribution width increased (P < or = 0.05). Consumption of the iron-fortified food product attenuated declines in iron status in iron-deficient anemic soldiers; a group-by-time interaction was observed for hemoglobin and sTfR concentrations (P < or = 0.05). Serum hepcidin concentrations were not affected by BCT; however, hepcidin concentrations were lower in iron-deficient anemic soldiers than in those with normal iron status (P < or = 0.05) and were positively associated with serum ferritin (P < or = 0.05) and C-reactive protein (P < or = 0.05) concentrations pre- and post-BCT. CONCLUSIONS: Twice-daily consumption of an iron-fortified food product improved iron status in iron-deficient anemic soldiers but not in iron-normal or iron-deficient nonanemic soldiers. Serum hepcidin concentrations were not affected by training but were associated with iron status and inflammation pre- and post-BCT. This trial was registered at clinicaltrials.gov as NCT01100905.
Authors: Peter Peeling; Alannah K A McKay; David B Pyne; Kym J Guelfi; Rachel H McCormick; Coby M Laarakkers; Dorine W Swinkels; Laura A Garvican-Lewis; Megan L R Ross; Avish P Sharma; Jill J Leckey; Louise M Burke Journal: Eur J Appl Physiol Date: 2017-04-13 Impact factor: 3.078
Authors: Claire E Badenhorst; Brian Dawson; Carmel Goodman; Marc Sim; Gregory R Cox; Christopher J Gore; Harold Tjalsma; Dorine W Swinkels; Peter Peeling Journal: Eur J Appl Physiol Date: 2014-02-01 Impact factor: 3.078
Authors: Víctor M Alfaro-Magallanes; Laura Barba-Moreno; Nuria Romero-Parra; Beatriz Rael; Pedro J Benito; Dorine W Swinkels; Coby M Laarakkers; Ángel E Díaz; Ana B Peinado Journal: Eur J Appl Physiol Date: 2022-09-21 Impact factor: 3.346
Authors: Jacqueline S Guimarães; Juçara G Cominal; Ana Cristina Silva-Pinto; Gordana Olbina; Yelena Z Ginzburg; Vijay Nandi; Mark Westerman; Stefano Rivella; Ana Maria de Souza Journal: Eur J Haematol Date: 2014-11-11 Impact factor: 2.997
Authors: Stefan M Pasiakos; J Philip Karl; Laura J Lutz; Nancy E Murphy; Lee M Margolis; Jennifer C Rood; Sonya J Cable; Kelly W Williams; Andrew J Young; James P McClung Journal: PLoS One Date: 2012-02-23 Impact factor: 3.240
Authors: Lee M Margolis; Stefan M Pasiakos; J Philip Karl; Jennifer C Rood; Sonya J Cable; Kelly W Williams; Andrew J Young; James P McClung Journal: Nutrients Date: 2012-12-18 Impact factor: 5.717
Authors: Irena Auersperger; Branko Škof; Bojan Leskošek; Bojan Knap; Aleš Jerin; Mitja Lainscak Journal: PLoS One Date: 2013-03-05 Impact factor: 3.240
Authors: James P McClung; Svein Martini; Nancy E Murphy; Scott J Montain; Lee M Margolis; Ingjerd Thrane; Marissa G Spitz; Janet-Martha Blatny; Andrew J Young; Yngvar Gundersen; Stefan M Pasiakos Journal: Nutr J Date: 2013-11-04 Impact factor: 3.271